Our Breakthrough Products
BMEYE creates totally non-invasive hemodynamic monitors that offer continuous, beat-to-beat, and real-time information on Cardiac Output, Blood Pressure, Fluid Responsiveness, Oxygen Delivery, and other critically important hemodynamic parameters. These integrated functional hemodynamic data empower clinicians to predict and proactively address the early signs of hemodynamic instability during surgery and in life-threatening situations. Today, BMEYE has two products approved for sale in the U.S. and Europe from this platform: Nexfin, for the Cardiology market, and ccNexfin, for the Anesthesia and Critical Care markets. For a list of clinical studies involving our breakthrough products, click here. |
BMEYE's FDA-cleared and CE-marked products are designed to provide fast diagnosis and to enable early goal-directed therapies in various clinical applications to improve patient care while reducing costs.